Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 11
2004 9
2005 16
2006 9
2007 16
2008 11
2009 23
2010 32
2011 37
2012 34
2013 25
2014 34
2015 56
2016 42
2017 45
2018 38
2019 28
2020 43
2021 42
2022 35
2023 29
2024 31
2025 37
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

615 results

Results by year

Filters applied: . Clear all
Page 1
Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea.
Hong SJ, Lee SJ, Lee SH, Lee JY, Cho DK, Kim JW, Kim SM, Hur SH, Heo JH, Jang JY, Koh JS, Won H, Lee JW, Hong SJ, Kim DK, Choe JC, Lee JB, Kim SJ, Yang TH, Lee JH, Hong YJ, Ahn JH, Lee YJ, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y, Kim BK; OCCUPI investigators. Hong SJ, et al. Among authors: lee jh. Lancet. 2024 Sep 14;404(10457):1029-1039. doi: 10.1016/S0140-6736(24)01454-5. Epub 2024 Sep 2. Lancet. 2024. PMID: 39236729 Clinical Trial.
Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trial.
Kim MC, Ahn JH, Hyun DY, Lim Y, Cho KH, Lee SH, Park S, Oh S, Sim DS, Hong YJ, Kim JH, Jeong MH, Cho JH, Lee SR, Kang DO, Hwang JY, Youn YJ, Lee JH, Jeong YH, Ahn JH, Kim DB, Choo EH, Kim CJ, Kim W, Rhew JY, Park JI, Yoo SY, Ahn Y; OPTION–STEMI Investigators. Kim MC, et al. Among authors: lee jh. Lancet. 2025 Sep 6;406(10507):1032-1043. doi: 10.1016/S0140-6736(25)01529-6. Epub 2025 Aug 31. Lancet. 2025. PMID: 40902612 Clinical Trial.
RAD51 wrestles with SUMO.
Kee Y, Lee JH, You HJ. Kee Y, et al. Among authors: lee jh. Mol Cell Oncol. 2022 Mar 31;9(1):2054263. doi: 10.1080/23723556.2022.2054263. eCollection 2022. Mol Cell Oncol. 2022. PMID: 35372672 Free PMC article.
Efficacy and Safety of Fimasartan, Atorvastatin, and Ezetimibe Combination Therapy in Patients With Hypertension and Dyslipidemia: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial.
Hong SJ, Kim JH, Cha KS, Lee JB, Moon JY, Cho GY, Cho DK, Park JP, Yi JE, Kim KH, Jeong H, Rhee MY, Lee JH, Ahn KT, Yoon YW, Lee SY, Sung KC, Cha TJ, Shin J, Cho YH, Son JW, Ahn JH, Park SD, Kang WC, Hahn JY, Ha JW. Hong SJ, et al. Among authors: lee jh. Clin Ther. 2025 Nov;47(11):1028-1036. doi: 10.1016/j.clinthera.2025.08.012. Epub 2025 Sep 14. Clin Ther. 2025. PMID: 40947318 Free article. Clinical Trial.
Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery.
Kang DY, Lee SH, Lee SW, Lee CH, Kim C, Jang JY, Mehta N, Oh JH, Cho YR, Yoon KH, Ahn SG, Lee JH, Cho DK, Kim Y, Kim J, Cho GH, Lee KS, Park H, Vural M, Lim YH, Park KH, Lee BK, Lee JY, Park HW, Yoon YH, Lee JH, Lee SY, Park KW, Kang J, Kim HK, Kang SH, Park JH, Choi IC, Yu CS, Yun SC, Park DW, Hong MK, Park SJ, Kim JS, Ahn JM; ASSURE DES Investigators. Kang DY, et al. Among authors: lee jh. J Am Coll Cardiol. 2024 Dec 10;84(24):2380-2389. doi: 10.1016/j.jacc.2024.08.024. Epub 2024 Aug 31. J Am Coll Cardiol. 2024. PMID: 39217573 Free article. Clinical Trial.
615 results